1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) is sponsored by National Human Genome Research Institute (NHGRI), National Institutes of Health (NIH). This Notice of Funding Opportunity (NOFO) invites Research Project Grant (R01) applications to study the ethical, legal, and social implications (ELSI) of human genetic or genomic research.
It encourages direct engagement with communities and other interested groups and is highly relevant to topics like Indigenous data sovereignty and community consent. The program is interested in research on the role of epistemic equality in genomic research with Indigenous populations and how genomic information impacts the conceptualization of race, ethnicity, and ancestry.
Get alerted about grants like this
Save a search for “National Human Genome Research Institute (NHGRI), National Institutes of Health (NIH)” or related topics and get emailed when new opportunities appear.
Search similar grants →According to the current listing, eligibility includes: Open to a wide range of academic disciplines. Eligible applicants include private institutions of higher education, public and state institutions of higher education, Native American tribal governments (Federally Recognized), and Native American tribal organizations (other than Federally recognized tribal governments). Confirm the full requirements in the official notice before applying.
Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) is funded by National Human Genome Research Institute (NHGRI), National Institutes of Health (NIH). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
Building Partnerships and Broadening Perspectives to Advance ELSI Research (BBAER) Program is sponsored by National Human Genome Research Institute (NHGRI), National Institutes of Health (NIH). This program supports transdisciplinary ELSI research, establishment of ELSI research teams that include partnerships with relevant communities, research capacity building, and workforce development opportunities. It is a limited competition, open to domestic organizations in the U.S. and its territories that received less than $30 million per year in total NIH funding for the past three fiscal years, as these organizations are underrepresented in NHGRI ELSI funding.
Investigator Initiated Innovation in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed) is a grant from the National Human Genome Research Institute (NHGRI) and National Library of Medicine (NLM) at NIH that funds innovative computational research to advance genomics and biomedical data science. The program (PAR-25-228) supports research that develops new computational methods, tools, and approaches for analyzing genomic data, and aligns with agency priorities in advancing data-driven genomic discovery. Eligible applicants include universities, research institutions, nonprofits, and other entities. This is an R01 research project grant with multiple annual receipt dates.
The Complement-ARIE program funds seven technology centers to develop human-based models that complement animal research. What it means for drug developers, academic researchers, and the regulatory pipeline.
Read articleNIH launched Complement-ARIE with $150M to develop organ-on-chip, AI models, and other NAMs that simulate human biology. What biotech researchers and grant seekers need to know.
Read articleWhile headlines chase AI and defense money, USDA's National Institute of Food and Agriculture runs a tight summer competitive cycle — Equipment Grants (June 25), Agricultural Genome to Phenome (June 29), New Beginning for Tribal Students (July 2), and Crop Protection and Pest Management (July 6). Here is how the four programs fit together, who is eligible, and why the land-grant system has a structural edge.
Read article